Stan Lapidus is the Founder, President, and CEO of SynapDx, a new company developing diagnostic tests for the early detection of autism.
Mr. Lapidus is an experienced life-science entrepreneur. Previously, Stanley was Co-Founder and Chairman of Helicos BioSciences. In 1995 he founded EXACT Sciences Corporation (NASDAQ: EXAS), an applied genomics company that develops and markets non-invasive, DNA-based methods for early detection of colorectal and other common cancers. He served as the CEO from 1995 to 2001 and Chairman of EXACT Sciences' Board of Directors from 2000 until the end of 2005. Prior to EXACT, Mr. Lapidus founded Cytyc Corporation (NASDAQ:CYTC) and was President and CEO from 1987 through 1994.
In addition to his entrepreneurial activities, Mr. Lapidus holds academic appointments in the Pathology Department at Tufts University Medical School and MIT's Sloan School of Management. He earned a BSEE from Cooper Union. He has served as a trustee of Cooper Union since 2002. Mr. Lapidus holds 31 issued patents.